Microbes Used as Biological Weapons: Bioterrorism Threats and Global Biosecurity Measures

Microorganisms have long been recognized not only for their role in disease and ecology but also for their potential misuse as biological weapons. The deliberate use of pathogens to cause harm commonly referred to as bioterrorism poses a significant threat to global security and public health. Biological agents that can be weaponized include bacteria, viruses, and toxins capable of causing widespread illness, social disruption, and economic damage. In the wrong hands, these agents can be deployed deliberately to create fear, destabilize societies, and overwhelm healthcare systems.

Historically, biological agents have attracted attention from extremist groups, rogue scientists, and, in some cases, state actors seeking strategic advantage. Unlike conventional weapons, biological agents can be relatively inexpensive to produce and difficult to detect in the early stages of an outbreak. Their capacity for rapid transmission among human populations makes them particularly dangerous when released intentionally. The use or threat of such agents can trigger widespread panic, disrupt trade and travel, and impose heavy burdens on medical and emergency response infrastructures.

However, the development, stockpiling, and use of biological weapons are internationally prohibited under agreements such as the Biological Weapons Convention (BWC), which came into force in 1975. This treaty obligates signatory nations to prohibit the development, production, and acquisition of microbial or other biological agents intended for hostile purposes. Many countries maintain strict regulatory frameworks and biosafety protocols governing laboratories that work with high-risk pathogens. Legitimate research institutions and public health agencies study dangerous microbes primarily for defensive purposes such as vaccine development, disease surveillance, and preparedness against natural outbreaks or potential bioterrorist events.

Despite these safeguards, concerns remain about the potential misuse of biological agents. Advances in biotechnology, synthetic biology, and genetic engineering have lowered barriers to manipulating microorganisms, raising fears that malicious actors could modify pathogens to increase their virulence, transmissibility, or resistance to treatment. Additionally, geopolitical tensions sometimes raise suspicions that certain nations might covertly maintain biological weapon capabilities despite international agreements.

Actionable Focus: Strengthening Global Biosecurity and Early Detection

To reduce the risk of bioterrorism, the international community must prioritize stronger biosecurity measures and transparent scientific oversight. Governments and research institutions should invest in robust pathogen monitoring systems, rapid disease detection technologies, and international data sharing networks that allow unusual outbreaks to be identified quickly. Training programs that promote responsible conduct in life sciences are also essential to prevent the misuse of biological knowledge. Furthermore, expanding international cooperation in public health surveillance, emergency response, and laboratory regulation can help ensure that biological research remains focused on protecting human health rather than threatening it.

State and Non-State Access to Biological and Chemical Weapons

Although biological weapons derived from microorganisms such as bacteria, viruses, and fungi are widely prohibited under international law, concerns persist about their potential development and use. Unlike many conventional weapons systems, biological agents can sometimes be produced with relatively modest infrastructure and technical expertise. This characteristic raises fears that both state and non-state actors could attempt to develop or acquire them clandestinely. While most governments publicly adhere to international agreements banning biological weapons, the possibility of covert research programs or unauthorized activities cannot be entirely dismissed, particularly in regions experiencing political instability or geopolitical tensions.

Bacteria: Bacterial pathogens are among the most frequently discussed biological agents because they can often be cultured and amplified under laboratory conditions. Certain bacterial species produce spores or possess environmental resilience, allowing them to survive outside a host for extended periods. Some bacteria can be transmitted through inhalation, ingestion, or contaminated surfaces, potentially leading to severe illness if deliberately released. For example, Bacillus anthracis, the bacterium that causes Anthrax, forms highly durable spores capable of persisting in soil or aerosolized environments. Because bacterial infections may initially resemble common illnesses, deliberate exposure could delay detection and complicate emergency responses.

Viruses: Viruses represent another category of potential biological agents due to their high infectivity and ability to spread rapidly through populations. Unlike bacteria, viruses require living host cells to replicate, but many can transmit efficiently through respiratory droplets, bodily fluids, or contaminated materials. Once introduced into a susceptible population, viral outbreaks may escalate quickly, particularly if the pathogen has a high reproduction rate or limited available treatment options. Certain viruses have historically been discussed in biosecurity contexts because of their capacity to cause severe epidemics or pandemics if deliberately disseminated.

Toxins: Toxins are poisonous substances produced by living organisms, including bacteria, plants, and fungi. Unlike bacteria or viruses, toxins do not reproduce within a host, but they can cause serious illness or death even at extremely small doses. Some toxins disrupt critical cellular processes such as protein synthesis or nerve signaling. One example frequently referenced in discussions of biological threats is Botulinum toxin, produced by Clostridium botulinum, which interferes with nerve function and can cause paralysis. Because toxins act quickly and may be difficult to detect in contaminated food or aerosols, they are considered a potential risk if misused.

In contrast to biological weapons, some nations historically maintained stockpiles of chemical warfare agents within their military arsenals. Chemicals such as Sarin and Sulfur Mustard (commonly known as mustard gas) have been produced and weaponized in the past due to their ability to cause severe injury, long-term health complications, and mass casualties. These substances were extensively used during conflicts in the twentieth century and later became the focus of international disarmament efforts. Today, the production, acquisition, and stockpiling of chemical weapons are prohibited under the Chemical Weapons Convention (CWC), which requires signatory states to destroy existing stockpiles and submit to verification by the Organisation for the Prohibition of Chemical Weapons (OPCW).

Despite these international frameworks, the potential involvement of non-state actors remains a serious concern. Well-funded private groups, extremist organizations, or criminal networks may attempt to acquire hazardous biological or chemical materials for malicious purposes. Access to advanced scientific knowledge, laboratory equipment, and global supply chains can make it possible for such actors to pursue illicit programs if regulatory oversight is weak. In extreme cases, these materials could be transferred to terrorist groups seeking to create fear, disruption, and casualties among civilian populations.

For these reasons, global security efforts increasingly emphasize monitoring, regulation, and cooperative enforcement. Governments, international organizations, and research institutions work together to strengthen laboratory biosafety standards, track the movement of hazardous chemicals and pathogens, and promote transparency in scientific research. Intelligence sharing, export controls on dual-use technologies, and strong legal frameworks are also essential components of preventing the misuse of biological and chemical materials.

Minimizing the risk of biological or chemical weapons proliferation requires sustained international collaboration. By reinforcing treaty compliance, supporting global inspection mechanisms, and promoting responsible scientific practices, the international community can reduce the likelihood that dangerous agents fall into the hands of actors who might use them to cause widespread harm and societal disruption.

International Oversight of Chemical and Biological Weapons

The global community has established strict frameworks to prevent the misuse of chemical and biological agents. The Chemical Weapons Convention (CWC), ratified by numerous nations particularly those with historical stockpiles of chemical weapons serves as a cornerstone in regulating these hazardous materials. The CWC obligates signatory states to eliminate existing stockpiles, prohibit development or production, and submit to rigorous international inspections to ensure compliance. Complementing this treaty, instruments such as the United Nations Disarmament Act provide additional legal and diplomatic mechanisms to restrict nations from deploying chemical or biological weapons, reinforcing the global norm against their use. These agreements emphasize transparency, requiring nations to continuously demonstrate adherence to international standards through monitoring and reporting mechanisms.

Biological agents, which include bacteria, viruses, fungi, and microbial toxins, are subject to similar oversight under these frameworks. While virtually all such agents carry inherent health risks, they are not considered immediate threats until weaponized and deliberately disseminated to target human or animal populations. Factors such as ease of production, environmental stability, and transmission potential influence their selection for malicious use. A wide range of microbes and metabolic products could technically meet the criteria of a weaponized biological agent, though regulatory bodies like the U.S. Centers for Disease Control and Prevention classify them based on public health impact and security risk. Table 1 highlights key distinguishing features of biological agents typically considered in bioterrorism scenarios, providing a framework for understanding their pathogenic potential, modes of transmission, and relative threat levels.

International oversight and continuous monitoring are critical for ensuring that nations respect prohibitions on chemical and biological weapons. By maintaining rigorous inspection regimes, promoting transparency, and enforcing legal consequences for noncompliance, these frameworks aim to minimize the risk of bioterrorism and protect global health and security.

Table 1. Summary of characteristics of selected bioterrorism agents

Agent	Incubation period	Person to person spread	Morbidity/mortality	Diagnosis*
B. anthracis	1-5 days	No	HIGH/HIGH	Culture/serology
Y. pestis	2-3 days	Yes	HIGH/HIGH	Culture/serology
F. tularensis	2-10 days	No	HIGH/LOW	Culture/serology
Brucella  spp.	5 days-two months	No	HIGH/LOW	Culture/serology
Botulinum toxins	1-5 days	No	HIGH/HIGH	ELISA or mouse inoculation for toxin detection
Variola virus	7–17 days	Yes	HIGH/HIGH	Detection via ELISA, PCR, or virus isolation
Viral hemorrhagic fever agents (e.g. Lassa virus and Ebola virus)	4 days–3 weeks	No	HIGH/HIGH	PCR, ELISA, serology, virus isolation
*ELISA = Enzyme-linked immunosorbent assay   PCR = Polymerase chain reaction

Classification of Biological Agents by Threat Level

The Centers for Disease Control and Prevention (CDC) has developed a systematic framework to categorize microbial agents based on their potential use in bioterrorism. Recognizing that not all pathogens pose the same level of threat, the CDC evaluates agents on the basis of infectivity, mortality, potential for person-to-person transmission, and the capacity to cause public panic or social disruption. This prioritization helps public health authorities allocate resources efficiently, design response strategies, and prepare for potential outbreaks, whether naturally occurring or deliberately introduced.

Biological agents are classified into three priority categories, reflecting the urgency and scale of public health interventions required in the event of exposure.

Category A Biological Agents: Category A includes the highest-risk pathogens that pose a significant threat to national security and public health. These agents can be easily disseminated or transmitted between individuals, often causing high mortality rates and severe public health consequences. Their rapid spread and potential to incite widespread fear make them the top priority for surveillance, preparedness, and emergency response planning. Examples include Bacillus anthracis (anthrax) and Variola virus (smallpox).

Category B Biological Agents: Category B agents are moderately easy to disseminate and generally result in lower mortality rates compared to Category A pathogens. While they may cause significant illness and pose challenges for public health infrastructure, they are less likely to trigger widespread panic. These agents require specific diagnostic capacity and public health planning to mitigate outbreaks effectively. Examples include Brucella species (brucellosis) and Ricin toxin, which can cause serious illness if deployed intentionally.

Category C Biological Agents: Category C encompasses emerging pathogens that could be engineered for mass dissemination in the future. Although currently less threatening, these agents are notable due to their potential for high morbidity and mortality and the likelihood of future misuse as biotechnology advances. Early surveillance and research are critical to prepare for potential threats from these microbes.

This classification framework provides public health authorities, governments, and security agencies with a structured approach to identify, monitor, and respond to biological threats, ultimately enhancing global preparedness against bioterrorism.

References

Aschengrau A and Seage G.R (2013). Essentials of Epidemiology in Public Health. Third edition. Jones and Bartleh Learning,

Aschengrau, A., & G. R. Seage III. (2009). Essentials of Epidemiology in Public Health.  Boston:  Jones and Bartlett Publishers.

Castillo-Salgado C (2010). Trends and directions of global public health surveillance. Epidemiol Rev, 32:93–109.

Centers for Disease Control and National Institutes of Health (1999). Biosafety in Microbiological and Biomedical Laboratories, 4th edn, Washington DC: CDC.

Guillemin J (2006). Scientists and the history of biological weapons. European Molecular Biology Organization (EMBO) Reports, Vol 7, Special Issue: S45-S49.

Halliday JE, Meredith AL, Knobel DL, Shaw DJ, Bronsvoort BMC, Cleaveland S (2007). A framework for evaluating animals as sentinels for infectious disease surveillance. J R Soc Interface, 4:973–984.

Nelson K.E and Williams C (2013). Infectious Disease Epidemiology: Theory and Practice. Third edition. Jones and Bartleh Learning. 

Porta M (2008). A dictionary of epidemiology. 5^th edition. New York: Oxford University Press.

Rothman K.J and Greenland S (1998). Modern epidemiology, 2^nd edition. Philadelphia: Lippincott-Raven. 

Rothman K.J, Greenland S and Lash T.L (2011). Modern Epidemiology. Third edition. Lippincott Williams and Wilkins, Philadelphia, PA, USA.